{"filing":{"accession_number":"0001437749-26-023651","cik":"0001058307","ticker":"NXPLW","company_name":"NextPlat Corp","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"nxpl20260714_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1058307/000143774926023651/nxpl20260714_8k.htm"},"events":[{"id":18236,"run_id":16387,"accession_number":"0001437749-26-023651","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"summary":"NextPlat Corp entered into a Membership Interest Purchase Agreement on July 14, 2026, to acquire 100% of Scott's Pharmacy, LLC for $1.5 million in cash. The acquisition is expected to close in Q4 2026 and will add approximately $5.6 million in profitable annual revenue while expanding the PharmcoRx retail footprint into the Pensacola, Florida market.","company_name":"NextPlat Corp","ticker":"NXPLW","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16986,"accession_number":"0001437749-26-023651","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"NextPlat Corp entered into a Membership Interest Purchase Agreement on July 14, 2026, to acquire 100% of Scott's Pharmacy, LLC for $1.5 million in cash. This is a material acquisition of a community pharmacy that will expand the Company's PharmcoRx retail footprint and add approximately $5.6 million in profitable annual revenue. The transaction is a definitive agreement for acquisition of a business asset, fitting squarely within Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:03:47.869191+00:00","company_name":"","ticker":null,"filing_date":""},{"id":16987,"accession_number":"0001437749-26-023651","item_number":"8.01","item_title":"Other Events.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"NextPlat announced entry into an agreement to acquire an independent pharmacy in Pensacola, Florida for $1.5 million in cash, expected to close in Q4 2026. The acquisition is material to the company's strategy, adding approximately $5.6 million in profitable annual revenue and expanding the PharmcoRx unit's geographic footprint into a new market. This constitutes a material acquisition under Item 1.01 of Form 8-K, disclosed here under Item 8.01 (Other Events).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:03:47.869191+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16986,"accession_number":"0001437749-26-023651","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"NextPlat Corp entered into a Membership Interest Purchase Agreement on July 14, 2026, to acquire 100% of Scott's Pharmacy, LLC for $1.5 million in cash. This is a material acquisition of a community pharmacy that will expand the Company's PharmcoRx retail footprint and add approximately $5.6 million in profitable annual revenue. The transaction is a definitive agreement for acquisition of a business asset, fitting squarely within Item 1.01 (Entry into a Material Definitive Agreement) and the ma_activity event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:03:47.869191+00:00","company_name":"NextPlat Corp","ticker":"NXPLW","filing_date":"2026-07-15"},{"id":16987,"accession_number":"0001437749-26-023651","item_number":"8.01","item_title":"Other Events.","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.95,"reasoning":"NextPlat announced entry into an agreement to acquire an independent pharmacy in Pensacola, Florida for $1.5 million in cash, expected to close in Q4 2026. The acquisition is material to the company's strategy, adding approximately $5.6 million in profitable annual revenue and expanding the PharmcoRx unit's geographic footprint into a new market. This constitutes a material acquisition under Item 1.01 of Form 8-K, disclosed here under Item 8.01 (Other Events).","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T10:03:47.869191+00:00","company_name":"NextPlat Corp","ticker":"NXPLW","filing_date":"2026-07-15"}]}